Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation

<b>Background/Objectives</b>: Catheter ablation has become the standard of care for patients with symptomatic and drug-refractory atrial fibrillation (AF). Both Class IC and Class III antiarrhythmic drugs (AADs) are effective in preventing early recurrences of AF, but not late recurrence...

詳細記述

書誌詳細

出版年:	Pharmaceuticals
主要な著者:	Andrej Belančić, Yusuf Ziya Sener, Metin Oksul, Cansu Ozturk, Serdar Soner, Adnan Duha Comert, Gamze Yeter Arslan, Dinko Vitezić, Bojan Jelaković, Erkan Baysal
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-07-01
主題:	antiarrhythmics amiodarone atrial fibrillation catheter ablation flecainide propafenone
オンライン･アクセス:	https://www.mdpi.com/1424-8247/18/7/1022